Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer
Tenon Medical (NASDAQ:TNON), a company focused on sacroiliac joint disorders, has appointed Kevin Williamson as Chief Financial Officer. Williamson, with extensive experience in medical device finance, succeeds Steve Van Dick. His background includes CFO roles at Accelus Inc. and finance positions at NuVasive, Inc. This appointment comes as Tenon approaches key milestones, including the completion of enrollment for their post-market clinical trial of The Catamaran SI Joint Fusion System. CEO Steve Foster highlighted Williamson's experience as important for Tenon's next growth phase. Williamson expressed enthusiasm about joining Tenon at this pivotal moment, aiming to manage sustainable revenue and create operating leverage as the company expands in the SI market.
Tenon Medical (NASDAQ:TNON), un'azienda focalizzata sui disordini dell'articolazione sacroiliaca, ha nominato Kevin Williamson come Direttore Finanziario. Williamson, con una vasta esperienza nel settore finanziario dei dispositivi medici, succede a Steve Van Dick. Il suo background include ruoli da CFO in Accelus Inc. e posizioni finanziarie in NuVasive, Inc. Questa nomina arriva mentre Tenon si avvicina a traguardi chiave, inclusa la conclusione dell'arruolamento per il loro studio clinico post-marketing del Catamaran SI Joint Fusion System. Il CEO Steve Foster ha sottolineato l'importanza dell'esperienza di Williamson per la prossima fase di crescita di Tenon. Williamson ha espresso entusiasmo per essersi unito a Tenon in questo momento cruciale, mirando a gestire entrate sostenibili e creare leva operativa mentre l'azienda si espande nel mercato SI.
Tenon Medical (NASDAQ:TNON), una empresa enfocada en trastornos de la articulación sacroilíaca, ha nombrado a Kevin Williamson como Director Financiero. Williamson, con una amplia experiencia en finanzas de dispositivos médicos, sucede a Steve Van Dick. Su trayectoria incluye roles de CFO en Accelus Inc. y posiciones financieras en NuVasive, Inc. Este nombramiento se produce mientras Tenon se acerca a hitos clave, incluida la finalización de la inscripción para su ensayo clínico post-comercialización del Sistema de Fusión de Articulación SI Catamaran. El CEO Steve Foster destacó la experiencia de Williamson como crucial para la próxima fase de crecimiento de Tenon. Williamson expresó entusiasmo por unirse a Tenon en este momento decisivo, con el objetivo de gestionar ingresos sostenibles y crear apalancamiento operativo a medida que la empresa se expande en el mercado de SI.
테논 메디컬(TENON Medical, NASDAQ:TNON)은 천장관절 장애에 주력하는 회사로, 케빈 윌리엄슨을 최고재무책임자로 임명했습니다. 의료 기기 재무에 대한 광범위한 경험을 가진 윌리엄슨은 스티브 반 딕을 이어 직무를 맡게 됩니다. 그의 경력에는 Accelus Inc.에서 CFO 역할과 NuVasive, Inc.에서의 재무직이 포함되어 있습니다. 이러한 임명은 테논이 카타마란 SI 관절 융합 시스템의 시장 출시 후 임상 시험 등록 마감에 가까워짐에 따라 이루어졌습니다. CEO 스티브 포스터는 윌리엄슨의 경험이 테논의 다음 성장 단계에 중요하다고 강조했습니다. 윌리엄슨은 이 중요한 순간에 테논에 합류하게 되어 기쁘다고 표현하며, 회사가 SI 시장에서 확장하면서 지속 가능한 수익을 관리하고 운영 레버리지를 창출하는 것을 목표로 하고 있습니다.
Tenon Medical (NASDAQ:TNON), une entreprise axée sur les troubles de l'articulation sacro-iliaque, a nommé Kevin Williamson au poste de directeur financier. Williamson, qui possède une vaste expérience dans le domaine du financement des dispositifs médicaux, succède à Steve Van Dick. Son parcours comprend des fonctions de directeur financier chez Accelus Inc. et des postes financiers chez NuVasive, Inc. Cette nomination intervient alors que Tenon approche de jalons clés, y compris l'achèvement de l'inscription pour leur essai clinique post-commercialisation du système de fusion de l'articulation SI Catamaran. Le PDG Steve Foster a souligné que l'expérience de Williamson est importante pour la prochaine phase de croissance de Tenon. Williamson a exprimé son enthousiasme à l'idée de rejoindre Tenon à ce moment décisif, visant à gérer des revenus durables et à créer un effet de levier opérationnel alors que l'entreprise se développe sur le marché SI.
Tenon Medical (NASDAQ:TNON), ein Unternehmen, das sich auf Sakroiliak-Gelenkstörungen konzentriert, hat Kevin Williamson zum Chief Financial Officer ernannt. Williamson, der umfangreiche Erfahrungen im Bereich der medizinischen Gerätefinanzierung hat, folgt auf Steve Van Dick. Sein beruflicher Werdegang umfasst CFO-Positionen bei Accelus Inc. und Finanzpositionen bei NuVasive, Inc. Diese Ernennung erfolgt, während Tenon wichtige Meilensteine erreicht, einschließlich des Abschlusses der Rekrutierung für ihre post-marketing klinische Studie des Catamaran SI Joint Fusion Systems. CEO Steve Foster hob hervor, dass Williams Erfahrung für die nächste Wachstumsphase von Tenon wichtig ist. Williamson äußerte Begeisterung darüber, in diesem entscheidenden Moment zu Tenon stoßen zu können, und strebt an, nachhaltige Einnahmen zu verwalten und eine operative Hebelwirkung zu schaffen, während das Unternehmen im SI-Markt expandiert.
- Appointment of experienced CFO Kevin Williamson with background in medical device finance
- Nearing completion of enrollment for post-market clinical trial of The Catamaran SI Joint Fusion System
- Upcoming release of interim analysis for the clinical study
- None.
LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has appointed Kevin Williamson as Chief Financial Officer. Mr. Williamson's appointment succeeds the previously disclosed retirement of Steve Van Dick from the role of Chief Financial Officer.
Mr. Williamson most recently served as the Chief Financial Officer at Accelus Inc., a medical device company focused on expandable spinal implant technology. In this role, Mr. Williamson was responsible for the finance organization, in addition to the investor relations and IT functions. From 2019 to 2020, Mr. Williamson served in the Director of Finance position at Accelus Inc., where he was responsible for Financial Planning and Analysis. From 2015 to 2019, Mr. Williamson held various roles of increasing responsibility in the Corporate Finance department at NuVasive, Inc., a California-based medical device company focused on minimally invasive spine surgery. Mr. Williamson holds a B.S. in Business Administration, Finance from San Diego State University and an M.B.A. from the University of San Diego Knauss School of Business.
Steve Foster, Chief Executive Officer of Tenon, commented, "With an extensive track record of financial leadership in the spinal related medical technology industry, we are thrilled to welcome Kevin as Tenon's new Chief Financial Officer. As we near completion of upcoming catalysts, including full enrollment of our post-market clinical trial for The Catamaran SI Joint Fusion System and the release of the study's interim analysis, Kevin's vast experience as a CFO and finance professional will be instrumental to strategically advance Tenon into our next phase of growth."
Mr. Williamson said, "It is an honor to join Tenon, and I would like to thank Steve and the Board for selecting me to fulfill this responsibility at this exciting inflection point in the Company's growth trajectory. I look forward to leveraging my financial oversight experience of private and public companies within the medical device industry by managing sustainable revenue while creating operating leverage, as Tenon penetrates the SI market to achieve its objective of reducing chronic SI pain and driving long-term value."
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran™ SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Tenon is underway with a national launch of this system to address the greatly underserved market opportunity that exists in this space. For more information, please visit www.tenonmed.com.
The Tenon Medical logo and Tenon Medical, are registered trademarks of Tenon Medical, Inc. Catamaran is a trademark of Tenon Medical, Inc.
Forward-Looking Statements
This press release contains "forward-looking statements," which are statements related to events, results, activities or developments that Tenon Medical expects, believes or anticipates will or may occur in the future. Forward-looking often contain words such as "intends," "estimates," "anticipates," "hopes," "projects," "plans," "expects," "seek," "believes," "see," "should," "will," "would," "target" and similar expressions and the negative versions thereof. Such statements are based on Tenon Medical's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances, and speak only as of the date made. Forward-looking statements are inherently uncertain and actual results may differ materially from assumptions, estimates or expectations reflected or contained in the forward-looking statements as a result of various factors. For details on the uncertainties that may cause our actual results to be materially different than those expressed in our forward-looking statements, please review our Annual Report on Form 10-K on file with the Securities and Exchange Commission ("SEC") at www.sec.gov, particularly the information contained in the section entitled "Risk Factors," and other SEC filings. We undertake no obligation to publicly update or revise any forward-looking statements to reflect new information or future events or otherwise unless required by law.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on accesswire.com
FAQ
Who is the new CFO of Tenon Medical (TNON)?
What is Kevin Williamson's background before joining Tenon Medical (TNON)?
What major milestones is Tenon Medical (TNON) approaching?
What is the focus of Tenon Medical's (TNON) business?
